|
(V317) |
Decision Support for Transcatheter Intervention in Sinus Venous Defects with Partial Anomalous Pulmonary Venous Drainage – Patient-specific Viability Assessment using In-Silico and In-Vitro Models |
|
|
A. Schleiger, M. Kelm, J. Nordmeyer, P. Kramer, L. Goubergrits, T. Kühne, F. Berger, J. Brüning (Berlin) |
|
|
Diskussion |
|
(V318) |
Disease severity is associated with distinct action potential shape in right ventricular myocardium of patients with congenital heart defects |
|
|
H. E. Fürniss, P. Iaconianni, E. M. Wülfers, J. Kroll, B. Stiller, P. Kohl, E. Rog-Zielinska, R. Peyronnet (Freiburg im Breisgau) |
|
|
Diskussion |
|
(V319) |
COVID-19 infections in adults with congenital heart disease |
|
|
N. Langes, S. J. Maurer, C. Meierhofer, N. Nagdyman, F. Bourier, S. Holdenrieder, P. Ewert, O. Tutarel (München) |
|
|
Diskussion |
|
(V320) |
Impact of COVID-19 on medical supply in adults with congenital heart disease |
|
|
S. Akkermann, T. Halling, F. Loeffler, A.-S. Silber-Peest, T. Krueger, S. Bleich, J. Bauersachs, K. G. Kahl, M. Westhoff-Bleck (Hannover) |
|
|
Diskussion |
|
(V321) |
Prediabetes predicts supraventricular tachycardia in adult congenital heart disease - independent of disease complexity and NT-proBNP elevation |
|
|
C. Hüsch, J. F. Kluge, L. H. Lemke, S. Hohmann, D. Duncker, J. Bauersachs, M. Westhoff-Bleck (Hannover) |
|
|
Diskussion |
|
(V322) |
Morphologic Alterations Precede Functional Hepatic Impairment as Determined by 13C-Methacetin Liver Function Breath Test in Adult Fontan Patients |
|
|
A. Schleiger, P. Kramer, H. Sallmon, N. Jentsch, M. Pileckaite, F. Danne, M. Schafstedde, H.-P. Müller, T. Müller, F. Tacke, M. Jara, M. Stockmann, F. Berger, S. Ovroutski, für die Studiengruppe: FoReCaRe (Berlin) |
|
|
Diskussion |